No abstract available
MeSH terms
-
Anticoagulants / adverse effects
-
Anticoagulants / therapeutic use
-
Antithrombins / adverse effects
-
Antithrombins / therapeutic use*
-
Coronary Angiography
-
Drug Therapy, Combination
-
Hemorrhage / chemically induced
-
Heparin / adverse effects
-
Heparin / therapeutic use
-
Hirudins / adverse effects
-
Hospital Mortality
-
Humans
-
Myocardial Infarction / diagnostic imaging
-
Myocardial Infarction / therapy*
-
Peptide Fragments / adverse effects
-
Peptide Fragments / therapeutic use*
-
Percutaneous Coronary Intervention*
-
Platelet Aggregation Inhibitors / administration & dosage
-
Platelet Aggregation Inhibitors / therapeutic use
-
Randomized Controlled Trials as Topic
-
Recombinant Proteins / adverse effects
-
Recombinant Proteins / therapeutic use
-
Recurrence
-
Stroke / epidemiology
-
Treatment Outcome
Substances
-
Anticoagulants
-
Antithrombins
-
Hirudins
-
Peptide Fragments
-
Platelet Aggregation Inhibitors
-
Recombinant Proteins
-
Heparin
-
bivalirudin